HomeEWTX • NASDAQ
add
Edgewise Therapeutics Inc
Previous close
$25.52
Day range
$25.29 - $26.30
Year range
$10.60 - $35.25
Market cap
2.76B USD
Avg Volume
1.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 46.86M | 15.89% |
Net income | -40.67M | -19.15% |
Net profit margin | — | — |
Earnings per share | -0.39 | -8.33% |
EBITDA | -46.34M | -16.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 563.34M | 14.38% |
Total assets | 583.47M | 14.12% |
Total liabilities | 24.82M | 10.77% |
Total equity | 558.65M | — |
Shares outstanding | 105.87M | — |
Price to book | 4.83 | — |
Return on assets | -19.58% | — |
Return on capital | -20.26% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -40.67M | -19.15% |
Cash from operations | -34.78M | -27.04% |
Cash from investing | 35.72M | 40.82% |
Cash from financing | 1.66M | -50.23% |
Net change in cash | 2.60M | 96.74% |
Free cash flow | -21.27M | -35.13% |
About
Founded
2017
Headquarters
Website
Employees
136
